Curcumin, the main active constituent of turmeric (Curcuma longa L.), induces apoptosis in hepatic stellate cells by modulating the abundance of apoptosis-related growth factors

Zeitschrift fur Naturforschung - Section C Journal of Biosciences

Volumn 70, Issue 11-12, 2015, Pages 281-285

  He, Ya Jun ^c   Kuchta, Kenny ^b   Lv, Xia ^c   Lin, Yu ^c   Ye, Guo Rong ^c   Liu, Xu You ^c   Song, Hui Dong ^c   Wang, Le Xin ^d   Kobayashi, Yuta ^e   Shu, Jian Chang ^a,d  

^a JINAN UNIVERSITY   (China)

^b NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^c Medical Corporation Soujikai   (Japan)

^d CHARLES STURT UNIVERSITY   (Australia)

^e SHIMANE UNIVERSITY   (Japan)

Author keywords

Apoptosis; Curcumin; Hepatic stellate cells

Indexed keywords

EID: 84957645484     PISSN: 09395075     EISSN: None     Source Type: Journal    
DOI: 10.1515/znc-2015-4143     Document Type: Article

References (18)

1. O'Connell MA, Rushworth SA. Curcumin: potential for hepatic fibrosis therapy? Br J Pharmacol 2008;153:403-5.
2. Jayaprakasha GK, Jena BS, Negi PS, Sakariah KK. Evaluation of antioxidant activities and antimutagenicity of turmeric oil: a byproduct from curcumin production. Z Naturforsch 2002;57c:828-35.
3. Egan ME, Pearson M, Weiner SA, Rajendran V, Rubin D, Glöckner-Pagel J, et al. Curcumin, a major constituent of turmeric, corrects cystic fibrosis defects. Science 2004;304:600-2.
4. Mall M, Kunzelmann K. Correction of the CF defect by curcumin: hypes and disappointments. Bioessays 2005;27:9-13.
5. Fiala M, Liu PT, Espinosa-Jeffrey A, Rosenthal MJ, Bernard G, Ringman JM, et al. Innate immunity and transcription of MGAT-III and Toll-like receptors in Alzheimer's disease patients are improved by bisdemethoxy curcumin. Proc Natl Acad Sci USA 2007;104:12849-54.
6. Hsu CH, Cheng AL. Clinical studies with curcumin. Adv Exp Med Biol 2007;595:471-80.
7. Ibrahim MA, Elbehairy AM, Ghoneim MA, Amer HA. Protective effect of curcumin and chlorophyllin against DNA mutation induced by cyclophosphamide or benzo[a]pyrene. Z Naturforsch 2007;62c:215-22.
8. Miriyala S, Panchatcharam M, Rengarajulu P. Cardioprotective effects of curcumin. Adv Exp Med Biol 2007;595:359-77.
9. Weisberg SP, Leibel R, Tortoriello DV. Dietary curcumin significantly improves obesity-associated inflammation and diabetes in mouse models of diabesity. Endocrinology 2008;149:3549-58.
10. Shu JC, He YJ, Lv X, Ye GR, Wang LX. Curcumin prevents liver fibrosis by inducing apoptosis and suppressing activation of hepatic stellate cells. J Nat Med 2009;63:415-20.
11. Shu JC, He YJ, Lv X, Zhao JR, Zhao J, Shen Y, et al. Effect of curcumin on the proliferation and apoptosis of hepatic stellate cells. Braz J Med Biol Res 2009;42:1173-8.
12. Park EJ, Jeon CH, Ko G, Kim J, Sohn DH. Protective effect of curcumin in rat liver injury induced by carbon tetrachloride. J Pharm Pharmacol 2000;52:437-40.
13. Bruck R, Ashkenazi M, Weiss S, Goldiner I, Shapiro H, Aeed H, et al. Prevention of liver cirrhosis in rats by curcumin. Liver Int 2007;27:373-83.
14. Xu J, Fu Y, Chen A. Activation of peroxisome proliferatoractivated receptor-gamma contributes to the inhibitory effects of curcumin on rat hepatic stellate cell growth. Am J PhysiolGastrointest-Liver Physiol 2003;285:G20-30.
15. Mackenzie GG, Queisser N, Wolfson L, Fraga CG, Adamo AM, Oteiza PI. Curcumin induces cell-arrest and apoptosis in association with the inhibition of constitutively active NF-kappaB and STAT3 pathways in Hodgkin's lymphoma cells. Int J Cancer 2008;123:56-65.
16. Shankar S, Srivastava RK. Bax and Bak genes are essential for maximum apoptotic response by curcumin, a polyphenolic compound and cancer chemopreventive agent derived from turmeric, Curcuma longa. Carcinogenesis 2007;28:1277-86.
17. Saile B, Knittel T, Matthes N. CD95/CD95L-mediated apoptosis of hepatic stellate cell. A mechanism terminating uncontrolled hepatic stellate cell proliferation during hepatic tissue repair. Am J Pathol 1997;151:1265-72.
18. Michael W, Stephan W, Christine S, Esser P, Fontana A, Dichgans J, et al. Topoisomerase-I inhibitors for human malignant glioma: differential modulation of p53, p21, Bax and Bcl-2 expression and of CD95-mediated apoptosis by camptothecin and β-lapachone. Int J Cancer 1997;73:707-14.